Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 Registry.
COVID-19
SARS-CoV-2
Spain
ethnic groups
migrants
minority groups
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
31 Mar 2022
31 Mar 2022
Historique:
received:
18
02
2022
revised:
26
03
2022
accepted:
28
03
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
(1) Background: This work aims to analyze clinical outcomes according to ethnic groups in patients hospitalized for COVID-19 in Spain. (2) Methods: This nationwide, retrospective, multicenter, observational study analyzed hospitalized patients with confirmed COVID-19 in 150 Spanish hospitals (SEMI-COVID-19 Registry) from 1 March 2020 to 31 December 2021. Clinical outcomes were assessed according to ethnicity (Latin Americans, Sub-Saharan Africans, Asians, North Africans, Europeans). The outcomes were in-hospital mortality (IHM), intensive care unit (ICU) admission, and the use of invasive mechanical ventilation (IMV). Associations between ethnic groups and clinical outcomes adjusted for patient characteristics and baseline Charlson Comorbidity Index values and wave were evaluated using logistic regression. (3) Results: Of 23,953 patients (median age 69.5 years, 42.9% women), 7.0% were Latin American, 1.2% were North African, 0.5% were Asian, 0.5% were Sub-Saharan African, and 89.7% were European. Ethnic minority patients were significantly younger than European patients (median (IQR) age 49.1 (40.5−58.9) to 57.1 (44.1−67.1) vs. 71.5 (59.5−81.4) years, p < 0.001). The unadjusted IHM was higher in European (21.6%) versus North African (11.4%), Asian (10.9%), Latin American (7.1%), and Sub-Saharan African (3.2%) patients. After further adjustment, the IHM was lower in Sub-Saharan African (OR 0.28 (0.10−0.79), p = 0.017) versus European patients, while ICU admission rates were higher in Latin American and North African versus European patients (OR (95%CI) 1.37 (1.17−1.60), p < 0.001) and (OR (95%CI) 1.74 (1.26−2.41), p < 0.001). Moreover, Latin American patients were 39% more likely than European patients to use IMV (OR (95%CI) 1.43 (1.21−1.71), p < 0.001). (4) Conclusion: The adjusted IHM was similar in all groups except for Sub-Saharan Africans, who had lower IHM. Latin American patients were admitted to the ICU and required IMV more often.
Identifiants
pubmed: 35407557
pii: jcm11071949
doi: 10.3390/jcm11071949
pmc: PMC8999367
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Infect Dis. 2021 Jun 1;72(11):e695-e703
pubmed: 32945846
BMJ Open. 2020 Aug 11;10(8):e039849
pubmed: 32784264
JAMA Netw Open. 2020 Oct 1;3(10):e2025197
pubmed: 33084902
Med Clin (Barc). 2021 Jun 11;156(11):558-560
pubmed: 33648722
J Gen Intern Med. 2021 Dec;36(12):3737-3742
pubmed: 34240284
J Med Virol. 2021 Jan;93(1):115-117
pubmed: 32558963
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Enferm Infecc Microbiol Clin (Engl Ed). 2018 Mar;36(3):187-193
pubmed: 28396090
Microorganisms. 2021 Aug 20;9(8):
pubmed: 34442851
EClinicalMedicine. 2021 Sep;39:101075
pubmed: 34493997
J Clin Med. 2021 Jun 13;10(12):
pubmed: 34199198
Obesity (Silver Spring). 2008 Mar;16(3):600-7
pubmed: 18239557
BMJ Open. 2021 Aug 31;11(9):e048952
pubmed: 34465581
Clin Immunol. 2020 Aug;217:108481
pubmed: 32473354
Clin Microbiol Infect. 2021 Apr;27(4):632.e1-632.e5
pubmed: 33246039
Ann Intern Med. 2021 Mar;174(3):362-373
pubmed: 33253040
N Engl J Med. 2020 Oct 15;383(16):1522-1534
pubmed: 32558485
BMJ Open. 2021 Jul 22;11(7):e048086
pubmed: 34301657
JAMA Netw Open. 2021 Oct 1;4(10):e2130479
pubmed: 34673962
J Microbiol Immunol Infect. 2020 Jun;53(3):425-435
pubmed: 32414646
JAMA. 2002 Jan 16;287(3):356-9
pubmed: 11790215
Rev Clin Esp. 2020 Nov;220(8):480-494
pubmed: 33994573
Health Syst Transit. 2010;12(4):1-295, xix-xx
pubmed: 21224176
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
PLoS One. 2020 Oct 28;15(10):e0240960
pubmed: 33112892
Lancet. 2017 Jul 15;390(10091):231-266
pubmed: 28528753
Nature. 2020 Nov;587(7835):610-612
pubmed: 32998156
Travel Med Infect Dis. 2021 Jul-Aug;42:102027
pubmed: 33757850
Eur J Hum Genet. 2020 Jun;28(6):715-718
pubmed: 32404885
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e28-e37
pubmed: 33103720
Clin Infect Dis. 2021 May 4;72(9):e206-e214
pubmed: 32674114
Eur J Public Health. 2014 Aug;24 Suppl 1:31-9
pubmed: 25107996
J Glob Health. 2021 Jun 26;11:05015
pubmed: 34221360
Rev Esp Quimioter. 2021 Dec;34(6):664-667
pubmed: 34622269
Lancet Reg Health Eur. 2021 Dec;11:100243
pubmed: 34751263
Ann Intern Med. 2020 Nov 17;173(10):773-781
pubmed: 32783686
Respirology. 2021 Dec;26(12):1181-1187
pubmed: 34459069
Rev Clin Esp (Barc). 2021 May;221(5):264-273
pubmed: 33998512
Clin Infect Dis. 2021 Dec 6;73(11):e4131-e4138
pubmed: 32827436